Table 1 Baseline Characteristics of patients in this study
Characteristics | No, of patients | Percent |
|---|---|---|
Age | ||
Median (Range) | 55.5 (42.0–72.0) | |
ECOG performance status | ||
Median (Range) | 2 (1–2) | |
Gender | ||
Male | 7 | 70% |
Female | 3 | 30% |
Race | ||
Asian | 10 | 100% |
Country | ||
South Korea | 10 | 100% |
Disease Type | ||
Gastric cancer | 5 | 50% |
Colorectal cancer | 3 | 30% |
Pancreas cancer | 1 | 10% |
Cholangiocarcinoma | 1 | 10% |
Disease Status | ||
Metastatic | 9 | 90% |
Recurrent | 1 | 10% |
Pathologic Type | ||
Well differentiated | 1 | 10% |
Moderate differentiated | 5 | 50% |
Poorly differentiated | 4 | 40% |
Metastatic sites | ||
Liver | 4 | 40% |
Lymph node | 7 | 70% |
Peritoneum | 3 | 30% |
No. of metastatic sites | ||
≤ 1 | 7 | 70% |
2 ≤ | 3 | 30% |
Prior lines of therapy | ||
2 | 3 | 30% |
3 | 4 | 40% |
4 | 1 | 10% |
5 | 2 | 20% |